购物车
- 全部删除
- 您的购物车当前为空
Sampatrilat is an effecive and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase. Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM).
Sampatrilat is an effecive and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase. Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 12,800 | 8-10周 | |
50 mg | ¥ 16,700 | 8-10周 | |
100 mg | ¥ 21,400 | 8-10周 |
产品描述 | Sampatrilat is an effecive and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase. Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM). |
靶点活性 | nACE:171.9 nM(ki), CACE:(ki)13.8 nM |
体内活性 | Sampatrilat (p.o.; 30 mg/kg; once a day; 5 weeks) decreases the mortality of the rats with CAL (20% versus 57% for untreated rats) and increase in the survival rate and improvement of the hemodynamic function of the rats with CAL [2]. |
别名 | UK-81252 |
分子量 | 584.68 |
分子式 | C26H40N4O9S |
CAS No. | 129981-36-8 |
密度 | 1.343g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容